For The Better

This midcap biotech could see huge success ahead — or disappointment.

You still have time to tap into these 401(k) benefits if you get started now.

Plenty of rich people are putting their future financial security in jeopardy.

These healthcare stocks can provide enviable long-term portfolio growth.

Occidental Petroleum stock has made investors small fortunes in recent years.

Based on its track record of compounding shareholder capital, investors have reasons to remain optimistic.

This small-cap biotech stock is surging. Time to buy?

Following the example of Charlie Munger can lead to many positive outcomes in your life.

This summer could provide two huge growth catalysts for this stock.

Is Canopy Growth closer to entering the U.S. cannabis market?

Nvidia bought this stock when it went public last fall.

Palantir stock surged 167% last year as the company capitalizes on artificial intelligence (AI).

Exxon has multiple catalysts to drive robust earnings growth through 2027.

These companies aren’t in danger of becoming has-beens.

Small-cap stocks have been underperforming the market, but that could change if investors begin gravitating toward value.

Energy Transfer continues to steadily increase its monster distribution.

NextEra Energy sees power demand growing significantly in the coming years.

This copper miner’s leaching initiative and substantive brownfield expansion opportunities put it in an ideal spot to benefit from an increase in the price of copper.

Billionaire investors are aggressively buying both Chevron and Altria Group stock.

The oil and gas giant has benefited from higher oil prices, and external factors could keep them high for longer.